Updated on 10 August 2016
Canberra: MTPConnect and ARCS Australia have signed a Memorandum of Understanding (MoU), agreeing to work closely together for the benefit of the MedTech, biotechnology and pharmaceutical industry.
In a signing ceremony at the ARCS Scientific Congress, MTPConnect Chair, Dr Bronwyn Evans, said she was delighted that ARCS were now officially one of MTPConnect's education affiliates, given the huge importance of up-skilling the sector in order to drive growth.
Also read: FDA granted EUA to Siemens' Zika assay
"ARCS is well respected for its role in the education, training and networking people working in the scientific disciplines of regulatory affairs, clinical research, health economics, medical affairs, medical information, pharmacovigilance and associated disciplines in the MTP sector, with a 2,000-person strong membership.
"This expertise in education dovetails with MTPConnect's remit to maximise the sector's competitive advantage and establish Australia as an Asia Pacific hub for medical technology, biotechnology and pharmaceutical companies.
Also read: Indian govt relaxes clinical trial norms